EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression

Chunyuan Luo, Juan He, Yang Yang, Ke Wu, Xin Fu, Jian Cheng, Yue Ming, Wenrong Liu, Yong Peng

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05797-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Chunyuan Luo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hosp…. Hauptthemen laut MEDLINE: Brain Neoplasms, CDC2 Protein Kinase, Cell Movement, Cell Proliferation. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Science and Technology Foundation of Sichuan Province, China, Postdoctoral Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioblastoma (GBM) is a highly aggressive and prevalent brain tumor that poses significant challenges in treatment. SRSF9, an RNA-binding protein, is essential for cellular processes and implicated in cancer progression. Yet, its function and mechanism in GBM need clarification.

Methods

Bioinformatics analysis was performed to explore differential expression of SRSF9 in GBM and its prognostic relevance to glioma patients. SRSF9 and CDK1 expression in GBM cell lines and patients’ tissues were quantified by RT-qPCR, Western blot or immunofluorescence assay. The role of SRSF9 in GBM cell proliferation and migration was assessed by MTT, Transwell and colony formation assays. Additionally, transcriptional regulation of CDK1 by SRSF9 was investigated using ChIP-PCR and dual-luciferase assays.

Results

The elevated SRSF9 expression correlates to GBM stages and poor survival of glioma patients. Through gain-of-function and loss-of-function strategies, SRSF9 was demonstrated to promote proliferation and migration of GBM cells. Bioinformatics analysis showed that SRSF9 has an impact on cell growth pathways including cell cycle checkpoints and E2F targets. Mechanistically, SRSF9 appears to bind to the promoter of CDK1 gene and increase its transcription level, thus promoting GBM cell proliferation.

Conclusions

These findings uncover the cellular function of SRSF9 in GBM and highlight its therapeutic potential for GBM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsCDC2 Protein KinaseCell MovementCell ProliferationGlioblastomaSerine-Arginine Splicing FactorsFemaleHumansMaleMiddle AgedCell Line, TumorGene Expression Regulation, NeoplasticPrognosis

Stichwörter der Autor:innen

CDK1GlioblastomaMigrationProliferationSRSF9

Substanzen

CDC2 Protein KinaseCDK1 protein, humanSerine-Arginine Splicing FactorsSRSF9 protein, human

Autor:innen und Institutionen

  • Laboratory of Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Laboratory of Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. hejuan@scu.edu.cn.
  • Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, 610041, China.
  • Laboratory of Molecular Oncology, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, 610041, China. yongpeng@scu.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Foundation of Sichuan Province, China
  • Postdoctoral Science Foundation of China

Zitieren

APA

Luo, C., He, J., Yang, Y., Wu, K., Fu, X., Cheng, J., Ming, Y., Liu, W., & Peng, Y. (2024). SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05797-0

Vancouver

Luo C, He J, Yang Y, Wu K, Fu X, Cheng J, et al. SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05797-0

BibTeX
@article{Luo2024,
  author = {Luo, Chunyuan and He, Juan and Yang, Yang and Wu, Ke and Fu, Xin and Cheng, Jian and Ming, Yue and Liu, Wenrong and Peng, Yong},
  title = {SRSF9 promotes cell proliferation and migration of glioblastoma through enhancing CDK1 expression},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05797-0}
}
Kostenlos starten →